drugset / Trial / NCT05009199

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

NCT05009199 ↗

Phase 1 Completed 3 enrolled Invicro
NaSingle-groupOpen-labelOther

Summary

The overall goal of this protocol is to evaluate the binding of caffeine to adenosine A2A receptors in the brain of participants at risk for developing PD.

Timeline

Start
2021-06-24
Primary completion
2022-05-12
Completion
2022-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]MNI-444 Diagnostic / imaging agent — Other

Indications

No indication recorded.